The legacy of Viagra, and its parent company copyright, presents a complex case study for investors. Originally a blockbuster drug, generating billions in revenue , its exclusivity period created a deluge of lower-priced alternatives , significantly diminishing its position . While some businesses may attempt to capitalize on related treatments , t